Effects of topical and systemic pirfenidone on postlaminectomy epidural fibrosis in a rat model
Turkish Journal of Medical Sciences · 15.10.2026 · 56 (5) · 1588-1597
DOI: 10.55730/1300-0144.6404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 15.10.2026. Verfasst von ÖZGÜR ÖCAL und 7 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: To investigate the effect of topical and systemic administration of pirfenidone (PFD) on the development of postlaminectomy epidural fibrosis in a rat model. Materials and methods: A total of 32 male Wistar albino rats were randomly assigned to four equal groups (n = 8 per group). A bilateral total L1–L2 laminectomy was performed using a posterior midline microsurgical approach. The control group received only laminectomy; the sterile saline (SF) group received laminectomy followed by irrigation with sterile saline; the topical pirfenidone (PFDTpc) group received laminectomy followed by topical PFD application at the laminectomy site; and the systemic pirfenidone (PFD-Sys) group received oral PFD. The postoperative day-30 endpoint was selected to allow histopathological assessment of mature epidural scar tissue and dural adhesions. The degree of fibrosis was assessed histopathologically. Plasma levels of matrix metalloproteinase-9 (MMP- 9), interleukin-6, vascular endothelial growth factor (VEGF), transforming growth factor beta-1 (TGF-β1), tumor necrosis factor alpha, hydroxyproline (HYP), and myeloperoxidase (MPO) were compared among the groups.
Results
In the control group, grade 2 epidural fibrosis was observed in two rats (25%), whereas grade 3 epidural fibrosis was observed in six rats (75%). The level of fibrosis in the SF group was similar to that in the control group. In the PFD-Tpc group, grade 1, 2, and 3 epidural fibrosis was observed in 25%, 50%, and 25% of the rats, respectively. In the PFD-Sys group, grade 1 epidural fibrosis was observed in four rats (50%) and grade 2 in four rats (50%); no grade 3 fibrosis was detected in this group. Plasma MMP-9 and HYP levels were significantly lower in the PFD-Tpc group compared with the control group (p < 0.05). Plasma MMP-9, VEGF, TGF-β1, HYP, and MPO levels were significantly lower in the PFD-Sys group than in the control group (p < 0.05). Systemic PFD showed the most consistent histopathological and biochemical reduction in fibrosis-associated parameters.
Conclusion
The histopathological and biochemical findings suggest that PFD, particularly via systemic administration, may attenuate postlaminectomy EF by reducing fibroproliferative activity, collagen-associated biochemical markers, angiogenic signaling, inflammatory response, and oxidative stress. PFD may be a promising pharmacological candidate for the prevention of postlaminectomy EF; however, further dose-response, pharmacokinetic, safety, and translational studies are required before clinical implementation.
Zitieren
APA
ÖCAL, Ö., YILDIRIM, Z., GÜNDOĞDU, A. Ç., TAŞ, A., YAMAN, B., ÇETİN, A., GÜRKAN, G., & AYCAN, A. (2026). Effects of topical and systemic pirfenidone on postlaminectomy epidural fibrosis in a rat model . Turkish Journal of Medical Sciences, 56(5), 1588-1597. https://doi.org/10.55730/1300-0144.6404
Vancouver
ÖCAL Ö, YILDIRIM Z, GÜNDOĞDU AÇ, TAŞ A, YAMAN B, ÇETİN A, et al. Effects of topical and systemic pirfenidone on postlaminectomy epidural fibrosis in a rat model . Turkish Journal of Medical Sciences. 2026;56(5):1588-1597. doi:10.55730/1300-0144.6404
BibTeX
@article{CAL2026,
author = {ÖCAL, ÖZGÜR and YILDIRIM, ZUHAL and GÜNDOĞDU, AYŞE ÇAKIR and TAŞ, ABDURRAHİM and YAMAN, BETÜL and ÇETİN, ABDURRAHMAN and GÜRKAN, GÖKHAN and AYCAN, ABDURRAHMAN},
title = {Effects of topical and systemic pirfenidone on postlaminectomy epidural fibrosis in a rat model },
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {5},
pages = {1588--1597},
doi = {10.55730/1300-0144.6404}
}
EUVIMED